Luca Gattinoni, M.D., holds the Chair for Functional Immune Cell Modulation at the University of Regensburg and directs a division at the Leibniz Institute for Immunotherapy. He earned his medical degree from the University of Milan (1998) and completed oncology residency at the National Cancer Institute in Milan (2003). At the U.S. National Cancer Institute, he conducted postdoctoral research under Dr. Nicholas Restifo (2003–2008), later serving as Staff Scientist (2008–2013) and Stadtman Investigator (2013–2019).
His research focuses on harnessing T cells to treat cancer. He discovered human stem cell memory T cells (Tscm) and has translated this into clinical adoptive cell therapy strategies. His lab investigates molecular and metabolic mechanisms underlying T cell stemness to improve immunotherapy effectiveness. He has published over 100 papers and received multiple awards, including the SITC Presidential Award (2004), Wilson S. Stone Memorial Award (2012), and NCI Director’s Intramural Innovation Award (2013).
Biography
M.D., holds the Chair for Functional Immune Cell Modulation at the University of Regensburg and directs a division at the Leibniz Institute for Immunotherapy.
Contact Form